← Back
Data updated: Jun 28, 2026
MEDEFIL INC
Pharma Pharmaceuticals
MEDEFIL INC is a pharmaceutical company with 4 FDA-approved products.
2012
Since
4
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules
MEDEFIL INC's Key Drugs
MEDEFIL INC's core commercial portfolio centers on CALCIUM CHLORIDE 10% — its most strategically important drugs approved in the last 15 years.
MEDEFIL INC's Recent FDA Approvals
New NDA/BLA approvals for MEDEFIL INC over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
MEDEFIL INC's Therapeutic Areas
Disease areas where MEDEFIL INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
MEDEFIL INC Pipeline Snapshot
Active clinical trials for MEDEFIL INC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • CALCIUM CHLORIDE 10% leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2012-01-06
- Latest
- 2022-11-04
- Applications
- 4